Synthesis and Manufacturing Processes for High-Purity SS-31 Research Peptide
Research Notice: This article covers research on SS-31 research peptide and MOTS-C research peptide — available from Palmetto Peptides for laboratory use only.
Research Disclaimer: SS-31 is sold by Palmetto Peptides strictly as a research compound for in vitro and laboratory use only.
Understanding how SS-31 is manufactured helps researchers evaluate material reliability. A well-synthesized and properly purified SS-31 batch is the foundation of reproducible mitochondrial research. Researchers can source high-purity SS-31 research peptide from Palmetto Peptides. For related context: BPC-157 research peptide science and NAD+ peptide research.
Solid-Phase Peptide Synthesis (SPPS): The Method
SS-31 is manufactured by Fmoc SPPS — the industry standard for research-grade peptides. The four residues (D-Arg, Dmt, Lys, Phe) are assembled sequentially C-to-N on a resin support. Unreacted reagents are washed away between each coupling step. After assembly, global deprotection and resin cleavage yield crude SS-31 for purification.
The Fmoc SPPS Cycle
- Coupling: Fmoc-protected amino acid + activating reagent reacts with free amine on resin-bound chain (30-60 min)
- Fmoc Deprotection: 20% piperidine in DMF removes Fmoc protecting group
- Washing: DMF washes remove piperidine and byproducts
- Repeat for all four residues
- Global cleavage: TFA cocktail removes side chain protecting groups and cleaves peptide from resin
The Special Challenges: Dmt and D-Arg
2',6'-Dimethyltyrosine (Dmt)
Dmt is not in standard amino acid libraries. Its sterically hindered ring slows coupling kinetics, requiring optimized protocols — extended coupling times, double-coupling, or highly activated reagents — to avoid truncation impurities.
D-Arginine
Requires the D-configured Fmoc-protected building block. The Pbf protecting group on the guanidinium side chain must be fully removed in the final cleavage step to avoid mass-shifted impurities.
Purification and Final Product
Crude SS-31 (typically 50-80% purity) undergoes preparative RP-HPLC, fraction pooling, analytical HPLC verification, and lyophilization to produce final dry powder at >=95-98% purity. See also: MOTS-C research, mitochondrial function research, longevity peptide research. Order SS-31 here.
Frequently Asked Questions
How is SS-31 synthesized?
By Fmoc SPPS: four residues assembled sequentially on resin, cleaved, deprotected, and purified by RP-HPLC.
What makes SS-31 synthesis challenging?
The non-standard Dmt building block and D-arginine residue require specialized protocols to achieve high purity without truncation or racemization impurities.
See Also: SS-31 Research Peptide: Complete Guide